These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9679951

  • 1. Absence or reduction of Fhit expression in most clear cell renal carcinomas.
    Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T, McCue PA, Pekarsky Y, Ohta M, Huebner K, Lubinski J.
    Cancer Res; 1998 Jul 15; 58(14):2946-51. PubMed ID: 9679951
    [Abstract] [Full Text] [Related]

  • 2. Different immunohistochemical patterns of Fhit protein expression in renal neoplasms.
    Eyzaguirre EJ, Miettinen M, Norris BA, Gatalica Z.
    Mod Pathol; 1999 Oct 15; 12(10):979-83. PubMed ID: 10530564
    [Abstract] [Full Text] [Related]

  • 3. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P, Wilhelm M, Kovacs G.
    Genes Chromosomes Cancer; 1997 Sep 15; 20(1):9-15. PubMed ID: 9290948
    [Abstract] [Full Text] [Related]

  • 4. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schröder JK, Bardenheuer W, Seeber S, Huebner K, Schütte J, Opalka B.
    Cancer Res; 2000 Jun 01; 60(11):2780-5. PubMed ID: 10850413
    [Abstract] [Full Text] [Related]

  • 5. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
    Zimonjic DB, Druck T, Ohta M, Kastury K, Croce CM, Popescu NC, Huebner K.
    Cancer Res; 1997 Mar 15; 57(6):1166-70. PubMed ID: 9067288
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF.
    Cancer Res; 1997 Sep 01; 57(17):3664-8. PubMed ID: 9288768
    [Abstract] [Full Text] [Related]

  • 7. FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
    Ramp U, Caliskan E, Ebert T, Karagiannidis C, Willers R, Gabbert HE, Gerharz CD.
    J Pathol; 2002 Apr 01; 196(4):430-6. PubMed ID: 11920739
    [Abstract] [Full Text] [Related]

  • 8. Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus.
    Velickovic M, Delahunt B, Grebe SK.
    Cancer Res; 1999 Mar 15; 59(6):1323-6. PubMed ID: 10096566
    [Abstract] [Full Text] [Related]

  • 9. Hypermethylation of the 5'CpG island of the FHIT gene in clear cell renal carcinomas.
    Kvasha S, Gordiyuk V, Kondratov A, Ugryn D, Zgonnyk YM, Rynditch AV, Vozianov AF.
    Cancer Lett; 2008 Jul 08; 265(2):250-7. PubMed ID: 18378390
    [Abstract] [Full Text] [Related]

  • 10. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S.
    Cancer Res; 1998 Nov 15; 58(22):5032-7. PubMed ID: 9823304
    [Abstract] [Full Text] [Related]

  • 11. FHITness and cancer.
    Druck T, Berk L, Huebner K.
    Oncol Res; 1998 Nov 15; 10(7):341-5. PubMed ID: 10063967
    [Abstract] [Full Text] [Related]

  • 12. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
    Ingvarsson S, Agnarsson BA, Sigbjornsdottir BI, Kononen J, Kallioniemi OP, Barkardottir RB, Kovatich AJ, Schwarting R, Hauck WW, Huebner K, McCue PA.
    Cancer Res; 1999 Jun 01; 59(11):2682-9. PubMed ID: 10363992
    [Abstract] [Full Text] [Related]

  • 13. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
    Guler G, Uner A, Guler N, Han SY, Iliopoulos D, Hauck WW, McCue P, Huebner K.
    Cancer; 2004 Apr 15; 100(8):1605-14. PubMed ID: 15073846
    [Abstract] [Full Text] [Related]

  • 14. Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12.
    Lott ST, Lovell M, Naylor SL, Killary AM.
    Cancer Res; 1998 Aug 15; 58(16):3533-7. PubMed ID: 9721855
    [Abstract] [Full Text] [Related]

  • 15. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
    Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P, Debiec H.
    Clin Cancer Res; 2005 Feb 01; 11(3):1190-7. PubMed ID: 15709188
    [Abstract] [Full Text] [Related]

  • 16. Expression of the multiple drug resistance gene in human renal cell carcinoma depends on tumor histology, grade, and stage.
    Tobe SW, Noble-Topham SE, Andrulis IL, Hartwick RW, Skorecki KL, Warner E.
    Clin Cancer Res; 1995 Dec 01; 1(12):1611-5. PubMed ID: 9815963
    [Abstract] [Full Text] [Related]

  • 17. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
    Yin DT, Wang L, Sun J, Yin F, Yan Q, Shen RL, Gao JX, He G.
    Ann Clin Lab Sci; 2010 Dec 01; 40(3):267-72. PubMed ID: 20689140
    [Abstract] [Full Text] [Related]

  • 18. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D, Santoro E, Hauck WW, Kovatich AJ, Rosato FE, Baffa R, Huebner K, McCue PA.
    Cancer; 2000 Jan 01; 88(1):24-34. PubMed ID: 10618602
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
    Genes Chromosomes Cancer; 1997 Sep 01; 20(1):98-102. PubMed ID: 9290961
    [Abstract] [Full Text] [Related]

  • 20. [The effect of FHIT gene on renal cell carcinomas].
    Chen X, Shen PF, Chen ZC.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct 28; 25(5):457-9. PubMed ID: 12212117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.